0001209191-19-061918.txt : 20191226
0001209191-19-061918.hdr.sgml : 20191226
20191226160514
ACCESSION NUMBER: 0001209191-19-061918
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191223
FILED AS OF DATE: 20191226
DATE AS OF CHANGE: 20191226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Thomas Patrick
CENTRAL INDEX KEY: 0001410514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 191310613
MAIL ADDRESS:
STREET 1: 60 WESTVIEW STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-23
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001410514
Kelly Thomas Patrick
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
Common Stock
2019-12-23
4
M
0
40000
1.89
A
40000
D
Common Stock
2019-12-23
4
S
0
40000
68.2092
D
0
D
Stock Option (Right to Buy)
1.89
2019-12-23
4
M
0
40000
0.00
D
2025-12-17
Common Stock
40000
83008
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $68.64, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 16 equal installments over a 4-year period following the vesting commencement date of February 23, 2015, subject to continued service through such dates.
/s/ Thomas P. Kelly
2019-12-26